Cystic fibrosis patients, doctors celebrate FDA's 'life-changing' approval of new treatment
November 01, 2019 at 09:26 AM EDT
The drug, Trikafta, is expected to be available to 90 percent of cystic fibrosis patients in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.